1333222-14-2 Usage
Uses
Used in Pharmaceutical Industry:
4-(trifluoroMethyl)pyriMidine-2-carbaldehyde is used as a building block for the synthesis of pharmaceuticals, leveraging its unique structure to create new molecules with potentially useful properties in drug development. The trifluoromethyl group can improve the metabolic stability and binding affinity of the resulting pharmaceuticals, which is crucial for their effectiveness and safety.
Used in Agrochemical Industry:
In the agrochemical sector, 4-(trifluoroMethyl)pyriMidine-2-carbaldehyde serves as a key intermediate in the synthesis of agrochemicals. Its application aids in the development of new compounds with enhanced properties, such as increased effectiveness against pests and diseases, and improved environmental stability, thereby contributing to more efficient and sustainable agricultural practices.
Used in Organic Chemistry Research:
4-(trifluoroMethyl)pyriMidine-2-carbaldehyde is utilized as a valuable intermediate in organic chemistry for the exploration and creation of novel molecular structures. Its presence in reactions can lead to the discovery of new compounds with a range of applications, from material science to biological research, due to its reactive aldehyde and trifluoromethyl groups.
Check Digit Verification of cas no
The CAS Registry Mumber 1333222-14-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,3,2,2 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1333222-14:
(9*1)+(8*3)+(7*3)+(6*3)+(5*2)+(4*2)+(3*2)+(2*1)+(1*4)=102
102 % 10 = 2
So 1333222-14-2 is a valid CAS Registry Number.
1333222-14-2Relevant academic research and scientific papers
PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS
-
, (2015/05/26)
Pyrido[2,3-d]pyrimidin-4-one compounds, formulations containing those compounds, and their use as tankyrase 1 and 2 inhibitors Formula (I).
IMIDAZOTRIAZINONE COMPOUNDS
-
Paragraph 0610; 0611; 0612, (2013/10/08)
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9 and pharmaceutically acceptable salt thereof. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including humans.
